Characteristics | Number (%) |
---|---|
Sex (female/male) | 63/56 |
Age (median) | 69 (32–91) |
Histopathological evaluation | |
Tumour localization | |
Caecum | 23 (19%) |
Ascending colon | 22 (18%) |
Hepatic flexure | 8 (7%) |
Transverse colon | 11 (9%) |
Splenic flexure | 4 (3%) |
Descending colon | 6 (5%) |
Sigmoid colon | 45 (38%) |
Tumor Stage | |
T1 | 10 (8%) |
T2 | 16 (13%) |
T3 | 93 (78%) |
Positive lymph node status | |
T1 tumours | 2/10 (20%) |
T2 tumours | 2/16 (12%) |
T3 tumours | 35/93 (38%) |
Stage | |
Stage I | 22 (18%) |
Stage II | 58 (49%) |
Stage III | 39 (33%) |
Lymph nodes, total number | |
Harvested lymph nodes PAD | 2542 |
Positive lymph nodes PAD | 123 |
CT evaluation | |
Detected lymph nodes ≥4 mm/tot | 442/1312 (34%) |
Region 1 | 261/835 (31%) |
Region 2 | 161/389 (41%) |
Region 3 | 20/88 (23%) |